Italy In-Vitro Diagnostics Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
Italy In-Vitro Diagnostics Market Outlook
Italy In-Vitro Diagnostics Market will reach US$ 3.59 Billion in 2028, according to Renub Research. In vitro means "in glass," indicating that the tests are conducted in controlled laboratory conditions rather than within a living organism. IVD, or In Vitro Diagnostics, are medical tests performed in a lab on samples like blood or urine. They help diagnose diseases, monitor treatment progress, and provide health information. IVD encompasses various tests like clinical chemistry, immunoassays, molecular diagnostics, microbiology, hematology, and histopathology. Common examples include glucose monitoring, cholesterol testing, pregnancy tests, HIV testing, genetic testing, and cancer biomarker analysis. IVD is vital for disease screening, early detection, patient management, and treatment monitoring, leading to improved outcomes and personalized medicine.
Italy In-Vitro Diagnostics Market shall grow at a CAGR of 6.65% during the forecast period of 2022 to 2028
The rising number of cases of chronic and infectious diseases and the aging population majorly add to Italy in-vitro diagnostics market growth. The publication titled "cardiovascular disease (CVD) Burden: Italian and global perspectives," available on Europe PMC, highlighted that Italy exhibits a substantially higher prevalence of cardiovascular disease (CVD) in comparison to the global average. The report indicates that Italy CVD prevalence is nearly double the global average (12.9% vs. 6.6%), while age-standardized figures show relatively similar rates (6.2% vs. 6.3%).
Additionally, technological advancements, government initiatives, healthcare reforms, growing emphasis on personalized medicine, and increasing awareness and patient empowerment will further improve Italy in-vitro diagnostics market in the future. Hence, the market value for Italy's in-vitro Diagnostics Market was US$ 2.44 Billion in 2022.
Services shall thrive in the Italy in-vitro diagnostics market
Italy's in-vitro diagnostics market is categorized into three product segments: Services, Instruments, and Reagents. Services dominate the Italy in-vitro diagnostics market due to factors such as the complexity of IVD tests and devices, regulatory compliance, training and education needs, customization and integration services, and value-added support. With sophisticated technologies requiring specialized expertise, service providers are relied upon for proper handling and maintenance. In addition, strict regulations ensure patient safety and reliability, increasing the demand for technical services. Providers also offer training programs, customization, and additional support beyond installation and maintenance. These factors collectively drive the leadership of services in Italy in-vitro diagnostics market.
PCR tests shall continue to have the highest market share in the Italy in-vitro diagnostics market
In the Italy in-vitro diagnostics market, there is a range of test types available, including ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others.PCR tests are known for their high sensitivity and specificity, allowing for accurate detection and identification of pathogens or genetic material, contributing to their widespread adoption. PCR technology has many applications beyond infectious disease diagnosis, including genetics and forensics.
PCR tests offer relatively quick turnaround times and have the advantage of being available on various platforms, which facilitates scalability. Furthermore, PCR tests have a long-established track record of diagnostics validity and regulatory approval, which has instilled confidence in healthcare providers. Finally, the COVID-19 pandemic has played a central role in the widespread adoption of PCR tests, further contributing to their high share in the Italy in-vitro diagnostics market.
Infectious diseases application is fastest growing in the Italy In-vitro diagnostics market
In the Italy In-vitro diagnostics market, various applications are of significant importance, including Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and other applications. Increased global travel and migration have facilitated the spread of infectious diseases across borders, making Italy susceptible to their introduction and transmission. Additionally, changing demographics and lifestyle factors, such as urbanization, population density, and high-risk activities, contribute to transmitting infectious agents.
Antimicrobial resistance has also played a significant role, highlighting the need for accurate diagnostics to guide appropriate treatment decisions. Outbreaks and epidemics, such as influenza, measles, and COVID-19, have increased the demand for rapid and accurate diagnostics for timely intervention and public health management. Increased awareness and proactive screening programs have further contributed to the growth, as they help identify infected individuals early and initiate appropriate treatment. Technological advancements, including molecular diagnostics and rapid point-of-care testing, have improved infectious disease diagnostics' capabilities and accuracy, fuelling their market growth.
Molecular Diagnostics/Genetics shall flourish during the forecast period
In the Italy In-vitro diagnostics market, various technologies are utilized, including Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and other technologies. Technological advancements like PCR, NGS, and gene expression profiling have improved genetic testing accuracy and accessibility. A greater understanding of genetics in disease development has increased the demand for molecular diagnostics. Precision medicine tailors’ treatment based on genetics, biomarkers, and disease characteristics, contributing to growth.
In cancer diagnostics, molecular diagnostics enable early detection, accurate diagnosis, and personalized treatment plans. Government initiatives support molecular diagnostics adoption through research investment and reimbursement policies. The rising demand for early disease detection and prevention fuels molecular diagnostics growth in the market. These factors drive growth, enhancing diagnostics capabilities and personalized medicine approaches, especially in cancer diagnostics.
Hospitals continue to have sovereignty in the Italy In-vitro diagnostics market
Segmentation of Italy's in-vitro diagnostics market based on end-users can break into four divisions: Hospitals, Laboratories, Home-Care, and Other sectors. Hospitals dominate the Italy in-vitro diagnostics (IVD) market due to their comprehensive healthcare services and seamless integration of diagnostics with other specialties. They possess the necessary infrastructure, resources, and skilled personnel for a robust IVD operation.
Being primary points of care, hospitals offer a wide range of medical services and act as referral centers. Their diverse clinical specialties ensure accurate diagnosis and interpretation of IVD test results. In addition, hospitals benefit from favorable reimbursement and funding mechanisms and adhere to stringent regulatory requirements, ensuring patient safety and test accuracy.
Key Players
In the Italy in-vitro diagnostics market, notable companies include Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation.
- In May 2022- The European Union's new In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR) took effect in Italy on May 26, 2022. While some existing devices are granted transition periods, the IVDR requirements now apply to all new in vitro diagnostics (IVDs) and specific low-risk IVDs already available in the market.
Renub Research report titled “Italy in-vitro diagnostics Market Global Forecast by Products (Services, Instruments, and Reagents), Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others), Application (Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and Others), End-Users (Hospitals, Laboratories, Home - Care, and Others), Company Analysis (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation)" provides a detailed analysis of Italy in-vitro Diagnostics Market.
Products - Market breakup from 3 Viewpoints:
1. Services
2. Instruments
3. Reagents
Test types - Market breakup from 11 Viewpoints:
1. ELISA & CLIA
2. PCR
3. Rapid Test
4. Fluorescence Immunoassays (FIA)
5. In Situ Hybridization
6. Transcription Mediated Amplification
7. Sequencing
8. Colorimetric Immunoassay
9. Radioimmunoassay (RIA)
10. Isothermal Nucleic Acid Amplification Technology
11. Others
Application - Market breakup from 8 Viewpoints:
1. Infectious Diseases
2. Diabetes
3. Cardiology
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Drug Testing
8. Others
Technology - Market breakup from 7 Viewpoints:
1. Immunoassay
2. Clinical Chemistry
3. Molecular Diagnostics/Genetics
4. Hematology
5. Microbiology
6. Coagulation
7. Others
End-Users - Market breakup from 4 Viewpoints:
1. Hospitals
2. Laboratories
3. Home – Care
4. Others
Company has been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue
Company Analysis:
1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
Report Details:
| Report Features | Details |
| Base Year | 2022 |
| Historical Period | 2018 - 2022 |
| Forecast Period | 2023 - 2028 |
| Market | US$ Billion |
| Segment Covered | Test Types, Technology, Products, Application, and End User |
| Companies Covered | Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamic
4.1 Growth Drivers
4.2 Challenges
5. Porter’s Five Forces
5.1 Bargaining Power of Buyer
5.2 Bargaining Power of Supplier
5.3 Threat of New Entrants
5.4 Rivalry among Existing Competitors
5.5 Threat of Substitute Products
6. SWOT Analysis
6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats
7. Italy In-Vitro Diagnostics (IVD) Market
8. Market Share – Italy In-Vitro Diagnostics (IVD)
8.1 By Test Types
8.2 By Technology
8.3 By Products
8.4 By Application
8.5 By End User
9. Test Types –Italy In-Vitro Diagnostics (IVD) Market
9.1 ELISA & CLIA
9.2 PCR
9.3 Rapid Test
9.4 Fluorescence Immunoassays (FIA)
9.5 In Situ Hybridization
9.6 Transcription Mediated Amplification
9.7 Sequencing
9.8 Colorimetric Immunoassay
9.9 Radioimmunoassay (RIA)
9.10 Isothermal Nucleic Acid Amplification Technology
9.11 Others
10. Product Types – Italy In-Vitro Diagnostics (IVD) Market
10.1 Services
10.2 Instruments
10.3 Reagents
11. Technology – Italy In-Vitro Diagnostics (IVD) Market
11.1 Immunoassay
11.2 Clinical Chemistry
11.3 Molecular Diagnostics/Genetics
11.4 Hematology
11.5 Microbiology
11.6 Coagulation
11.7 Others
12. Application – Italy In-Vitro Diagnostics (IVD) Market
12.1 Infectious Disease
12.2 Diabetes
12.3 Cardiology
12.4 Oncology
12.5 Nephrology
12.6 Autoimmune Diseases
12.7 Drug Testing
12.8 Other Applications
13. End User – Italy In-Vitro Diagnostics (IVD) Market
13.1 Hospitals
13.2 Laboratories
13.3 Home - Care
13.4 Others
14. Government Rules & Regulation
15. Reimbursement
15.1 Public
15.2 Private & Insurance
16. Company Analysis
16.1 Roche Diagnostics
16.1.1 Overview
16.1.2 Resent Development
16.1.3 Revenue
16.2 Abbott Diagnostics
16.2.1 Overview
16.2.2 Resent Development
16.2.3 Revenue
16.3 Siemens Healthineers
16.3.1 Overview
16.3.2 Resent Development
16.3.3 Revenue
16.4 Danaher Corporation
16.4.1 Overview
16.4.2 Resent Development
16.4.3 Revenue
16.5 Thermo Fisher Scientific
16.5.1 Overview
16.5.2 Resent Development
16.5.3 Revenue
16.6 Sysmex Corporation
16.6.1 Overview
16.6.2 Resent Development
16.6.3 Revenue
List of Figures:
Figure-01: Italy – In-Vitro Diagnostics (IVD) Market (Billion US$), 2018 – 2022
Figure-02: Italy – Forecast for In-Vitro Diagnostics (IVD) Market (Billion US$), 2023 – 2028
Figure-03: Test Types – ELISA & CLIA Market (Million US$), 2018 – 2022
Figure-04: Test Types – Forecast for ELISA & CLIA Market (Million US$), 2023 – 2028
Figure-05: Test Types – PCR Market (Million US$), 2018 – 2022
Figure-06: Test Types – Forecast for PCR Market (Million US$), 2023 – 2028
Figure-07: Test Types – Rapid Test Market (Million US$), 2018 – 2022
Figure-08: Test Types – Forecast for Rapid Test Market (Million US$), 2023 – 2028
Figure-09: Test Types – Fluorescence Immunoassays (FIA) Market (Million US$), 2018 – 2022
Figure-10: Test Types – Forecast for Fluorescence Immunoassays (FIA) Market (Million US$), 2023 – 2028
Figure-11: Test Types – In Situ Hybridization Market (Million US$), 2018 – 2022
Figure-12: Test Types – Forecast for In Situ Hybridization Market (Million US$), 2023 – 2028
Figure-13: Test Types – Transcription Mediated Amplification Market (Million US$), 2018 – 2022
Figure-14: Test Types – Forecast for Transcription Mediated Amplification Market (Million US$), 2023 – 2028
Figure-15: Test Types – Sequencing Market (Million US$), 2018 – 2022
Figure-16: Test Types – Forecast for Sequencing Market (Million US$), 2023 – 2028
Figure-17: Test Types – Colorimetric Immunoassay Market (Million US$), 2018 – 2022
Figure-18: Test Types – Forecast for Colorimetric Immunoassay Market (Million US$), 2023 – 2028
Figure-19: Test Types – Radioimmunoassay (RIA) Market (Million US$), 2018 – 2022
Figure-20: Test Types – Forecast for Radioimmunoassay (RIA) Market (Million US$), 2023 – 2028
Figure-21: Test Types – Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2018 – 2022
Figure-22: Test Types – Forecast for Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2023 – 2028
Figure-23: Test Types – Others Market (Million US$), 2018 – 2022
Figure-24: Test Types – Forecast for Others Market (Million US$), 2023 – 2028
Figure-25: Product Types – Services Market (Million US$), 2018 – 2022
Figure-26: Product Types – Forecast for Services Market (Million US$), 2023 – 2028
Figure-27: Product Types – Instruments Market (Million US$), 2018 – 2022
Figure-28: Product Types – Forecast for Instruments Market (Million US$), 2023 – 2028
Figure-29: Product Types – Reagents Market (Million US$), 2018 – 2022
Figure-30: Product Types – Forecast for Reagents Market (Million US$), 2023 – 2028
Figure-31: Technology – Immunoassay Market (Million US$), 2018 – 2022
Figure-32: Technology – Forecast for Immunoassay Market (Million US$), 2023 – 2028
Figure-33: Technology – Clinical Chemistry Market (Million US$), 2018 – 2022
Figure-34: Technology – Forecast for Clinical Chemistry Market (Million US$), 2023 – 2028
Figure-35: Technology – Molecular Diagnostics/Genetics Market (Million US$), 2018 – 2022
Figure-36: Technology – Forecast for Molecular Diagnostics/Genetics Market (Million US$), 2023 – 2028
Figure-37: Technology – Hematology Market (Million US$), 2018 – 2022
Figure-38: Technology – Forecast for Hematology Market (Million US$), 2023 – 2028
Figure-45: Technology – Microbiology Market (Million US$), 2018 – 2022
Figure-46: Technology – Forecast for Microbiology Market (Million US$), 2023 – 2028
Figure-39: Technology – Coagulation Market (Million US$), 2018 – 2022
Figure-40: Technology – Forecast for Coagulation Market (Million US$), 2023 – 2028
Figure-41: Technology – Others Market (Million US$), 2018 – 2022
Figure-42: Technology – Forecast for Others Market (Million US$), 2023 – 2028
Figure-43: Application – Infectious Disease Market (Million US$), 2018 – 2022
Figure-44: Application – Forecast for Infectious Disease Market (Million US$), 2023 – 2028
Figure-47: Application – Diabetes Market (Million US$), 2018 – 2022
Figure-48: Application – Forecast for Diabetes Market (Million US$), 2023 – 2028
Figure-49: Application – Cardiology Market (Million US$), 2018 – 2022
Figure-50: Application – Forecast for Cardiology Market (Million US$), 2023 – 2028
Figure-51: Application – Oncology Market (Million US$), 2018 – 2022
Figure-52: Application – Forecast for Oncology Market (Million US$), 2023 – 2028
Figure-53: Application – Nephrology Market (Million US$), 2018 – 2022
Figure-54: Application – Forecast for Nephrology Market (Million US$), 2023 – 2028
Figure-55: Application – Autoimmune Diseases Market (Million US$), 2018 – 2022
Figure-56: Application – Forecast for Autoimmune Diseases Market (Million US$), 2023 – 2028
Figure-57: Application – Drug Testing Market (Million US$), 2018 – 2022
Figure-58: Application – Forecast for Drug Testing Market (Million US$), 2023 – 2028
Figure-59: Application – Other Applications Market (Million US$), 2018 – 2022
Figure-60: Application – Forecast for Other Applications Market (Million US$), 2023 – 2028
Figure-61: End User – Hospitals Market (Million US$), 2018 – 2022
Figure-62: End User – Forecast for Hospitals Market (Million US$), 2023 – 2028
Figure-63: End User – Laboratories Market (Million US$), 2018 – 2022
Figure-64: End User – Forecast for Laboratories Market (Million US$), 2023 – 2028
Figure-65: End User – Home - Care Market (Million US$), 2018 – 2022
Figure-66: End User – Forecast for Home - Care Market (Million US$), 2023 – 2028
Figure-67: End User – Others Market (Million US$), 2018 – 2022
Figure-68: End User – Forecast for Others Market (Million US$), 2023 – 2028
Figure-69: Roche Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-70: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-71: Abbott Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-72: Abbott Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-73: Siemens Healthineers – Global Revenue (Billion US$), 2018 – 2022
Figure-74: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Danaher Corporation – Global Revenue (Billion US$), 2018 – 2022
Figure-76: Danaher Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77: Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2022
Figure-78: Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Sysmex Corporation – Global Revenue (Million US$), 2018 – 2022
Figure-80: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
List of Tables:
Table-01: Italy – In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2018 – 2022
Table-02: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2023 – 2028
Table-03: Italy – In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2018 – 2022
Table-04: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2023 – 2028
Table-05: Italy – In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2018 – 2022
Table-06: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2023 – 2028
Table-07: Italy – In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2018 – 2022
Table-08: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2023 – 2028
Table-09: Italy – In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2018 – 2022
Table-10: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2023 – 2028
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com